What was good got us here. What we need now is something different. It’s up to us to make that

As we step into 2026, one thing is certain: the ambiguity that defined the past 18 months has finally lifted.

Across industries, a quiet revolution in leadership is underway. Boards and executive teams are rethinking how they access capability –

As we close out a period of sustained uncertainty, many leaders across pharma, medtech, and diagnostics are asking the same

In an industry where innovation accelerates faster than most leaders can keep up with, time can feel like a constant

Imposter syndrome is becoming increasingly common in healthcare and life sciences, affecting leaders at every level. Understanding how it shows

McKinsey’s latest outlook on the US healthcare market is more than a financial projection – it is a guide to

As we wrap up this year, I’ve been reflecting on just how significant – and unusual – it has been